Researchers presented key findings at the 2026 american society of clinical oncology conference, including updates on treatments for non-small cell lung cancer and small cell lung cancer. Some studies reported significant benefits from certain therapies, such as reduced risk of death or extended progression-free survival. The conference highlighted potential practice-changing developments in cancer research, although the specific implications and future directions of these findings are still being discussed.